Kenyon, E., C. Eklund, J. Simmons, AND R. Pegram. FACTORS INFLUENCING PREDICTION OF BROMODICHLOROMETHANE (BDCM) IN EXHALED BREATH: FURTHER EVALUATION OF A HUMAN BDCM PBPK MODEL. Society of Toxicology, San Antonio, Texas, March 11 - 15, 2018.

Kenyon, E., R. Pegram, J. Lipscomb, AND R. Hines. Impact of Scaling Factor Variation on Pharmacokinetic Outcomes in Pediatric Populations: a Case Study Using Bromodichloromethane (BDCM). FutureTox IV, Crystal City, VA, November 14 - 16, 2018.

Kenyon, E. AND M. Hughes. Oral Exposure and Absorption of Toxicants. Chapter 1, Comprehensive Toxicology, 3rd ed. Elsevier: Oxford, OXFORD, Uk, 1:98-111, (2018).

Rooney, J., N. Ryan, B. Chorley, S. Hester, E. Kenyon, Judy Schmid, BJ George, M. Hughes, Y. Sey, A. Tennant, D. MacMillan, J. Simmons, C. McQueen, A. Pandiri, C. Wood, AND C. Corton. Genomic effects of androstenedione and sex-specific liver cancer susceptibility in mice. TOXICOLOGICAL SCIENCES. Society of Toxicology, RESTON, VA, 160(1):15–29, (2017).

Pegram, R., E. Kenyon, Steve Simmons, D. DeMarini, B. Chorley, A. Teal, AND T. Ross. Molecular Mechanisms by Which Chlorinated Water Causes Bladder Cancer. 48th Annual Meeting of the Environmental Mutagenesis and Genomics Society, Raleigh, North Carolina, September 09 - 13, 2017.

Kenyon, E., C. Eklund, R. Pegram, AND J. Simmons. PBPK-MODEL ESTIMATES OF BROMODICHLOROMETHANE (BDCM) DELIVERY TO THE HUMAN URINARY BLADDER. Gordon Research Conference, Mt Holyoke, Massachusetts, July 30 - August 04, 2017.

Kenyon, E., R. Pegram, AND R. Hines. Scaling Factor Variability and Toxicokinetic Outcomes in Children. Childrens Environmental Health Network Research Conference, Washington, DC, April 05 - 07, 2017.

Kenyon, E., J. Lipscomb, R. Pegram, AND R. Hines. THE IMPACT OF SCALING FACTOR VARIABILITY ON RISK-RELEVANT TOXICOKINETIC OUTCOMES IN CHILDREN: A CASE STUDY USING BROMODICHLOROMETHANE (BDCM). Society of Toxicology, Baltimore, Maryland, March 12 - 16, 2017.

Kenyon, E., T. Leavens, C. Eklund, AND R. Pegram. Development and Application of a Human PBPK Model for Bromodichloromethane (BDCM) to Investigate Impacts of Multi-Route Exposure. JOURNAL OF APPLIED TOXICOLOGY. John Wiley & Sons, Ltd., Indianapolis, IN, 36(9):1095-1111, (2015).

Lake, A., C. Wood, V. Bhat, B. Chorley, G. Carswell, Y. Sey, E. Kenyon, B. Padnos, T. Moore, A. Tennant, Judy Schmid, BJ George, D. Ross, M. Hughes, C. Corton, J. Simmons, C. McQueen, AND S. Hester. Dose and Effect Thresholds for Early Key Events in a Mode of PPARa-Mediated Action. TOXICOLOGICAL SCIENCES. Society of Toxicology, RESTON, VA, 149(2):312-325, (2016).

Kenyon, E., C. Eklund, J. Simmons, AND R. Pegram. PBPK-MODEL ESTIMATES OF BROMODICHLOROMETHANE (BDCM) DISTRIBUTION IN URINE AND BLADDER TISSUE. Society of Toxicology, New Orleans, LA, March 12 - 17, 2016.

Kenyon, E., C. Eklund, J. Lipscomb, AND R. Pegram. The impact of variation in scaling factors on the estimation of internal dose metrics: a case study using bromodichloromethane (BDCM). Toxicology Mechanisms and Methods. Taylor & Francis, Inc., Philadelphia, PA, 26(8):620-626, (2016).

Garcia, R., J. Ibrahim, J. Wambaugh, E. Kenyon, AND Woodrow Setzer. Identifiability of PBPK Models with Applications to Dimethylarsinic Acid Exposure. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS. Springer, New York, NY, , 1-19, (2015).

Kenyon, E. AND H. Clewell III. Toxicokinetics and Pharmacokinetic Modeling of Arsenic. Edition 1, Chapter 22, J. Christopher States (ed.), Arsenic: Exposure Sources, Health Risks, and Mechanism of Toxicity, edited by J. Christopher States, Chpt. 27, John Wiley & Sons, Inc., Hoboken, NJ. John Wiley & Sons Incorporated, New York, NY, 1:884-908, (2015).